| Registry | NCT05975866 |
|---|---|
| Status | Unknown |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: quadruple, supportive care |
| Enrollment | 60 (Estimated) |
| Sponsor | National Nutrition and Food Technology Institute (Other) |
| Conditions | Thyroid Diseases, Hypothyroidism, Hashimoto Disease |
| Interventions | curcumin, Anti-inflammatory diet (Dietary supplement, behavioral) |
| Dates | start 2023-09-23 (estimated), primary completion 2025-04-19 (estimated), completion 2025-06-30 (estimated), first posted 2023-08-04, last updated 2023-08-04 |
| Locations | 1 site in Iran |
Related Papers Related Patents Related Grants Related Experts
All trials for Thyroid Diseases All trials for Hypothyroidism All trials of curcumin All trials of Anti-inflammatory diet
The goal of this clinical trial is to investigate The effects of an anti-inflammatory diet with or without curcumin supplementation on anthropometric measurements, concentrations of thyroid hormones, anti-TPO, and systemic inflammation in plasma and NFK-B in peripheral blood mononuclear cells in patients with Hashimoto.
The main questions it aims to answer are:
1. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in anthropometric measurements (weight, body mass index, BMI, waist circumference, waist-to-hip ratio) in patients with Hashimoto's disease?
2. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in the serum concentration of thyroid hormones (T3, T4, TSH) in patients with Hashimoto's disease?
3. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the change of Anti-TPO concentration in patients with Hashimoto's disease?
4. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in systemic inflammation indicators (hs-CRP, IL-6) in plasma and NF-κB in peripheral blood mononuclear cells in patients with Hashimoto's disease?
| Arm | Type | Interventions | Description |
|---|---|---|---|
| The group receiving anti-inflammatory diet with curcumin supplement | Experimental | Dietary Supplement: curcumin; Behavioral: Anti-inflammatory diet | Implementation of an anti-inflammatory diet along with the daily consumption of three 500 mg curcumin capsules along with the main meals of breakfast, lunch, and dinner. |
| Group receiving anti-inflammatory regimen with curcumin placebo | Placebo comparator | Behavioral: Anti-inflammatory diet | Implementation of an anti-inflammatory diet along with the daily consumption of three 500 mg placebo capsules of curcumin (microcrystalline cellulose) and the main meals of breakfast, lunch, and dinner. |
Sex: All, ages: 20 Years to 70 Years
Inclusion Criteria: Having Hashimoto's thyroiditis Willingness to cooperate Body mass index between 35 and 18.5 TSH less than ten and without clinical symptoms Not taking levothyroxine tablets Exclusion Criteria: Pregnancy and breastfeeding kidney Diseases Follow non-routine weight loss diets for three months before the start of the study × Taking slimming and fat-burning drugs, fiber powder Mineral, vegetable, and fiber vitamin supplements
| Facility | City | Country | Status |
|---|---|---|---|
| Golbon Sohrab | Tehran, National Nutrition and Food Technology Research Institute | Iran |